Filing Details

Accession Number:
0001181431-12-057265
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-07 14:48:22
Reporting Period:
2012-11-06
Filing Date:
2012-11-07
Accepted Time:
2012-11-07 14:48:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278710 Robert Coffman C/O Dynavax Technologies
2929 Seventh Street, Suite 100
Berkeley CA 94710
Chief Scientific Officer & Vp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Stock Option Acquisiton 2012-11-06 8,000 $1.50 27,926 No 4 M Direct
Common Stock Disposition 2012-11-06 8,000 $4.31 19,926 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2012-11-06 8,000 $0.00 8,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-01-21 No 4 M Direct
Footnotes
  1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2012.
  2. This Stock Option was granted on January 22, 2003 with an expiration of January 21, 2013 and vested over a four-year period after the date of the grant.
  3. Not applicable.